These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36648224)

  • 1. Impact of Vancomycin Loading Doses and Dose Escalation on Glomerular Function and Kidney Injury Biomarkers in a Translational Rat Model.
    Chang J; Pais GM; Engel PL; Klimek P; Marianski S; Valdez K; Scheetz MH
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0127622. PubMed ID: 36648224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular Function and Urinary Biomarker Changes between Vancomycin and Vancomycin plus Piperacillin-Tazobactam in a Translational Rat Model.
    Chang J; Pais GM; Valdez K; Marianski S; Barreto EF; Scheetz MH
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0213221. PubMed ID: 35007142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A translational rat model to assess glomerular function changes with vancomycin.
    Pais GM; Chang J; Liu J; Scheetz MH
    Int J Antimicrob Agents; 2022 May; 59(5):106583. PubMed ID: 35378229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model.
    Chang J; Pais GM; Marianski S; Valdez K; Lesnicki E; Barreto EF; Rhodes NJ; Yarnold PR; Scheetz MH
    bioRxiv; 2023 Mar; ():. PubMed ID: 36945555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.
    Rhodes NJ; Prozialeck WC; Lodise TP; Venkatesan N; O'Donnell JN; Pais G; Cluff C; Lamar PC; Neely MN; Gulati A; Scheetz MH
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5742-51. PubMed ID: 27431226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.
    O'Donnell JN; Rhodes NJ; Lodise TP; Prozialeck WC; Miglis CM; Joshi MD; Venkatesan N; Pais G; Cluff C; Lamar PC; Briyal S; Day JZ; Gulati A; Scheetz MH
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.
    Pais GM; Avedissian SN; O'Donnell JN; Rhodes NJ; Lodise TP; Prozialeck WC; Lamar PC; Cluff C; Gulati A; Fitzgerald JC; Downes KJ; Zuppa AF; Scheetz MH
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.
    Avedissian SN; Pais GM; O'Donnell JN; Lodise TP; Liu J; Prozialeck WC; Joshi MD; Lamar PC; Becher L; Gulati A; Hope W; Scheetz MH
    J Antimicrob Chemother; 2019 Aug; 74(8):2326-2334. PubMed ID: 31065686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model.
    Pais GM; Liu J; Avedissian SN; Hiner D; Xanthos T; Chalkias A; d'Aloja E; Locci E; Gilchrist A; Prozialeck WC; Rhodes NJ; Lodise TP; Fitzgerald JC; Downes KJ; Zuppa AF; Scheetz MH
    J Antimicrob Chemother; 2020 May; 75(5):1228-1236. PubMed ID: 32011685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies.
    O'Donnell JN; Rhodes NJ; Miglis CM; Catovic L; Liu J; Cluff C; Pais G; Avedissian S; Joshi MD; Griffin B; Prozialeck W; Gulati A; Lodise TP; Scheetz MH
    Int J Antimicrob Agents; 2018 Feb; 51(2):239-243. PubMed ID: 28803934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary Metabolomics From a Dose-Fractionated Polymyxin B Rat Model of Acute Kidney Injury.
    Locci E; Liu J; Pais GM; Chighine A; Kahnamoei DA; Xanthos T; Chalkias A; Lee A; Hauser AR; Chang J; Rhodes NJ; d'Aloja E; Scheetz MH
    Int J Antimicrob Agents; 2022 Jul; 60(1):106593. PubMed ID: 35460851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiplexed UPLC-MS/MS assay for the simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis.
    Tengstrand E; Zhang H; Liu N; Dunn K; Hsieh F
    Toxicol Appl Pharmacol; 2019 Mar; 366():54-63. PubMed ID: 30653977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pharmacodynamic-Toxicodynamic Relationship of AUC and
    Avedissian SN; Pais G; Liu J; O'Donnell JN; Lodise TP; Neely M; Prozialeck WC; Lamar PC; Becher L; Scheetz MH
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as early biomarkers for predicting vancomycin-associated acute kidney injury: a prospective study.
    Pang HM; Qin XL; Liu TT; Wei WX; Cheng DH; Lu H; Guo Q; Jing L
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4203-4213. PubMed ID: 29028077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical chronic kidney disease modifies the diagnosis of experimental acute kidney injury.
    Succar L; Pianta TJ; Davidson T; Pickering JW; Endre ZH
    Kidney Int; 2017 Sep; 92(3):680-692. PubMed ID: 28476556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium.
    Zhou Y; Vaidya VS; Brown RP; Zhang J; Rosenzweig BA; Thompson KL; Miller TJ; Bonventre JV; Goering PL
    Toxicol Sci; 2008 Jan; 101(1):159-70. PubMed ID: 17934191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats.
    Vinken P; Starckx S; Barale-Thomas E; Looszova A; Sonee M; Goeminne N; Versmissen L; Buyens K; Lampo A
    Toxicol Pathol; 2012 Oct; 40(7):1049-62. PubMed ID: 22581811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Fetal and Maternal Vancomycin-Induced Kidney Injury during Pregnancy in a Rat Model.
    Joshi MD; Pais GM; Chang J; Hlukhenka K; Avedissian SN; Gulati A; Prozialeck WC; Lamar PC; Zhang Z; Scheetz MH; Griffin B
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.
    Hosohata K; Ando H; Fujimura A
    J Pharmacol Exp Ther; 2012 Jun; 341(3):656-62. PubMed ID: 22399813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching Services.
    Wagner P; Arnold J; Sheridan K
    Int J Gen Med; 2022; 15():7685-7692. PubMed ID: 36226308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.